Newsfeeds Archive - Page 16 of 194

1 minute read

M&A
News

Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE Announced Continuation of Business Combination Close Process

October 5, 1:42 PM

Athena Consumer Acquisition Corp. (“Athena Consumer”) (NYSE:ACAQ) announced today that the conditions to closing the business combination between Athena Consumer, Next.e.GO Mobile SE (“e.GO”),

ACAQ

1 minute read

M&A
News

Horizon Therapeutics Announced Acquisition By Amgen Approved By The High Court Of Ireland

By Charles Gross

October 5, 7:39 AM

-8-K As previously disclosed, on December 11, 2022, Horizon Therapeutics plc (“Horizon”), Amgen Inc. (“Amgen”) and Pillartree Limited, a whollyowned subsidiary of Amgen (“Acquirer

AMGN

1 minute read

Germany’s Bundeskartellamt Announced Users Now Have Better Choice On How Google Processes Their Data

By Charles Gross

October 5, 4:42 AM

Alphabet Inc., Google’s parent company, gives users better choice as to how Google processes their data according to Commitments undertaken by Google. The Commitments are the result of a proceeding conducted by the

EWG

1 minute read

News

Uber Earlier Announced “Return A Package” Feature, To Have A Courier Pick Up Your Prepaid And Sealed Packages And Drop Them Off At A Local Post Office, UPS, Or FedEx

By Charles Gross

October 4, 7:12 AM

Uber's mission is to change the way people, food, and things move through cities. With the launch of Uber Connect three years ago, we've simplified the way you can send items to friends, family or colleagues

UBER

1 minute read

General Motors Entered Into A New 364-day Revolving Credit Agreement With JPMorgan Chase Bank; Provides Available Borrowing Capacity Of $6B And Matures On October 1, 2024

By Charles Gross

October 4, 6:34 AM

-8-K On October 3, 2023, General Motors Company (“GM”) entered into a new 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders named

1 minute read

News

Mullen Automotive Confirmed That It Does Not Have Any Existing, Nor Does It Intend To In The Future Enter Into Any, Agreement Or Arrangement With Hardge Or EVT

By Charles Gross

October 4, 6:05 AM

As previously reported on a Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2023, Mullen Automotive Inc. (the "Company") terminated its agreement with Lawrence Hardge,

MULN

2 minute read

Uncategorized

On October 3, 2023, Zymergen, Subsidiary Of Ginkgo Bioworks And Certain Of Its Subsidiaries, Filed Voluntary Petitions For Relief Under Chapter 11 Of The United States Bankruptcy Code

By Charles Gross

October 3, 6:59 AM

On October 3, 2023, Zymergen Inc. (“Zymergen”), a wholly-owned subsidiary of Ginkgo Bioworks Holdings, Inc. (“Ginkgo”), and certain of its subsidiaries, filed voluntary petitions for relief under

DNA

1 minute read

On October 2, 2023, Trisalus Life Sciences Entered Into A Standby Equity Purchase Agreement With Ya Ii Pn, Ltd.

By Charles Gross

October 3, 6:11 AM

On October 2, 2023, TriSalus Life Sciences, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with YA II PN, Ltd. (“Yorkville”).

TLSI

1 minute read

Legal
News

AstraZeneca Announced Earlier, It Settled Nexium Liability Litigations; AstraZeneca To Make Payment Of $425M

By Charles Gross

October 3, 4:45 AM

AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements effectively resolve the product liability claims that are currently pending in the

AZN

1 minute read

News

Novartis Earlier Announced The Phase III APPLAUSE-IgAN Study Met Its Pre-specified Interim Analysis Primary Endpoint, Demonstrating Superiority Of Iptacopan Vs Placebo In Proteinuria Reduction

By Charles Gross

October 2, 4:42 AM

Novartis today announced positive top-line results from the pre-specified interim analysis of the Phase III APPLAUSE-IgAN study (NCT04578834) at 9 months1. Iptacopan, an investigational factor B inhibitor targeting the

NVS